Role of Hepatic Drug Transporters in Drug Development.

about

Preclinical Evaluation of [F]LCATD as a PET Tracer to Study Drug-Drug Interactions Caused by Inhibition of Hepatic Transporters

P2860

Q57113842-8076703D-D895-46F8-A6A0-862629306AF7

P2860

Role of Hepatic Drug Transporters in Drug Development.

Item

http://www.wikidata.org/entity/Q51659233

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Role of Hepatic Drug Transporters in Drug Development.

@en

Role of Hepatic Drug Transporters in Drug Development.

@nl

type

Item

label

Role of Hepatic Drug Transporters in Drug Development.

@en

Role of Hepatic Drug Transporters in Drug Development.

@nl

prefLabel

Role of Hepatic Drug Transporters in Drug Development.

@en

Role of Hepatic Drug Transporters in Drug Development.

@nl

P1476

Role of Hepatic Drug Transporters in Drug Development.

@en

P2093

Houfu Liu

http://www.w3.org/2001/XMLSchema#string

Jasminder Sahi

http://www.w3.org/2001/XMLSchema#string

P2860

Drug-induced perturbations of the bile acid pool, cholestasis, and hepatotoxicity: mechanistic considerations beyond the direct inhibition of the bile salt export pump

ITC recommendations for transporter kinetic parameter estimation and translational modeling of transport-mediated PK and DDIs in humans

Membrane transporters in drug development

Reduced physiologically-based pharmacokinetic model of repaglinide: impact of OATP1B1 and CYP2C8 genotype and source of in vitro data on the prediction of drug-drug interaction risk.

Prediction of organic anion-transporting polypeptide 1B1- and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity data.

Protein abundance of clinically relevant multidrug transporters along the entire length of the human intestine.

Prediction of pharmacokinetic profile of valsartan in human based on in vitro uptake transport data.

Mechanistic Modeling Reveals the Critical Knowledge Gaps in Bile Acid-Mediated DILI

Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte data.

The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy.

P304

S11-22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCPH.703

http://www.w3.org/2001/XMLSchema#string

P478

56 Suppl 7

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27385168

http://www.w3.org/2001/XMLSchema#string

Role of Hepatic Drug Transporters in Drug Development.

about

P2860

P2860

Role of Hepatic Drug Transporters in Drug Development.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698